VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
EXPO
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
EXPOExponent, Inc.
$59.70$2.9B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksEXPOFinancials

Exponent, Inc. (EXPO) Financials

30Y historyFree accessUpdated daily

Revenue growth momentum has accelerated to 14.3% as of 2026Q1, though operating margins remain sensitive to utilization rates, fluctuating between 12.1% and 30.5% over the last ten quarters.

EXPO Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMJan'26Jan'25Dec'23Dec'22Dec'21Jan'21Jan'20Dec'18Dec'17Dec'16Jan'16Jan'15Jan'14Dec'12Dec'11Dec'10Jan'10Jan'09Dec'07Dec'06Dec'05Dec'04Jan'04Jan'03Dec'01Dec'00Dec'99Jan'99Jan'98Jan'97
Sales/Revenue602.81M582.01M558.51M536.77M513.29M466.27M399.9M417.2M379.52M347.8M315.08M312.83M304.7M296.17M292.65M272.45M248.75M227.88M228.84M205.15M168.5M155.2M151.51M139.68M126.06M104.5M101.6M93.27M85.5M73.5M58.7M
Revenue Growth %7.82%4.21%4.05%4.57%10.09%16.6%-4.15%9.93%9.12%10.39%0.72%2.67%2.88%1.2%7.42%9.52%9.16%-0.42%11.55%21.75%8.57%2.43%8.47%10.81%20.63%2.85%8.93%9.09%16.33%25.21%0.51%
Cost of Goods Sold459.36M436.71M416.23M401M348.79M342.06M303.76M25.81M24.88M18.14M15.88M17.13M15.49M16.13M26.09M182.63M171.74M162.28M156.11M43.67M31.64M30.95M31.59M31.63M17.62M17.36M12.47M11.86M67.9M56.4M43.9M
COGS % of Revenue-75.03%74.52%74.71%67.95%73.36%75.96%6.19%6.56%5.21%5.04%5.47%5.09%5.44%8.92%67.03%69.04%71.21%68.22%21.29%18.78%19.94%20.85%22.65%13.98%16.61%12.28%12.72%79.42%76.73%74.79%
Gross Profit143.45M145.31M142.28M135.76M164.5M124.21M96.14M391.39M354.64M329.66M299.2M295.7M289.21M280.04M266.56M89.81M77.02M65.61M72.72M161.48M136.86M124.24M119.92M108.05M108.44M87.14M89.13M81.41M17.6M17.1M14.8M
Gross Margin %23.8%24.97%25.48%25.29%32.05%26.64%24.04%93.81%93.44%94.79%94.96%94.53%94.91%94.56%91.08%32.97%30.96%28.79%31.78%78.71%81.22%80.06%79.15%77.35%86.02%83.39%87.72%87.28%20.58%23.27%25.21%
Gross Profit Growth %-2.13%4.8%-17.47%32.44%29.2%-75.44%10.36%7.58%10.18%1.18%2.25%3.27%5.06%196.79%16.61%17.39%-9.79%-54.96%17.99%10.15%3.61%10.99%-0.36%24.45%-2.23%9.48%362.55%2.92%15.54%-5.73%
Operating Expenses26.72M25.52M22.73M24.44M23.66M15.28M12.89M306.28M288.07M275.75M253.16M243.9M241.16M240.22M235.03M36.35M33.78M194.62M192.12M131.53M116.67M103.86M100.59M91.14M94.52M77.52M78.46M73.42M13.3M10.6M13.3M
OpEx % of Revenue-4.38%4.07%4.55%4.61%3.28%3.22%73.41%75.9%79.28%80.35%77.96%79.14%81.11%80.31%13.34%13.58%85.4%83.95%64.12%69.24%66.92%66.39%65.25%74.98%74.18%77.23%78.72%15.56%14.42%22.66%
Selling, General & Admin26.72M25.52M22.73M24.44M287.89M293.33M262.93M272.72M232.58M228.07M208.89M199.8M199.38M198.8M185.37M13.12M12.36M173.28M13.39M131.53M116.67M103.86M100.59M91.14M94.52M77.52M74.03M69.01M8.8M7M9.7M
SG&A % of Revenue-4.38%4.07%4.55%56.09%62.91%65.75%65.37%61.28%65.57%66.3%63.87%65.43%67.12%63.34%4.81%4.97%76.04%5.85%64.12%69.24%66.92%66.39%65.25%74.98%74.18%72.87%73.99%10.29%9.52%16.52%
Research & Development0000000000000000000000000000000
R&D % of Revenue-------------------------------
Other Operating Expenses0000-264.24M-278.05M-250.04M33.56M-890K9.16M6.53M1.99M4.27M7.87M3.8M23.24M21.41M21.34M22.61M00000004.43M4.42M4.5M3.6M3.6M
Operating Income116.73M119.79M119.56M111.32M140.84M108.93M83.25M85.11M91.46M72.05M61.91M68.93M63.55M55.95M57.62M53.46M43.24M33.26M36.72M29.94M20.19M20.38M19.32M16.9M13.92M9.62M10.66M7.98M4.3M6.5M1.5M
Operating Margin %19.36%20.58%21.41%20.74%27.44%23.36%20.82%20.4%24.1%20.72%19.65%22.04%20.86%18.89%19.69%19.62%17.38%14.6%16.05%14.6%11.98%13.13%12.75%12.1%11.04%9.2%10.49%8.56%5.03%8.84%2.56%
Operating Income Growth %-0.19%7.4%-20.96%29.3%30.84%-2.19%-6.94%26.93%16.38%-10.19%8.47%13.59%-2.91%7.78%23.63%30%-9.42%22.64%48.32%-0.94%5.46%14.33%21.42%44.74%-9.8%33.56%85.65%-33.85%333.33%-40%
EBITDA126.84M129.87M129.25M120.24M147.92M115.41M90.12M91.92M97.75M78.34M68.04M74.41M68.95M60.9M62.33M57.87M47.56M37.61M40.83M33.79M23.82M23.81M22.61M20.27M17.34M14.3M15.1M12.4M8.8M10.1M5.1M
EBITDA Margin %21.04%22.31%23.14%22.4%28.82%24.75%22.54%22.03%25.76%22.52%21.6%23.79%22.63%20.56%21.3%21.24%19.12%16.51%17.84%16.47%14.14%15.34%14.92%14.51%13.76%13.68%14.86%13.29%10.29%13.74%8.69%
EBITDA Growth %-11.38%0.48%7.49%-18.71%28.17%28.07%-1.96%-5.97%24.78%15.13%-8.56%7.92%13.23%-2.3%7.71%21.67%26.45%-7.88%20.84%41.87%0.02%5.32%11.54%16.9%21.26%-5.27%21.75%40.9%-12.87%98.04%-15%
D&A (Non-Cash Add-back)10.11M10.08M9.69M8.92M7.08M6.49M6.87M6.81M6.29M6.29M6.13M5.48M5.4M4.95M4.71M4.41M4.32M4.35M4.11M3.85M3.63M3.43M3.29M3.37M3.42M4.68M4.43M4.42M4.5M3.6M3.6M
EBIT151.88M147.3M147.37M135.9M132.23M125.84M83.25M85.11M91.46M72.05M61.91M68.93M63.55M55.95M61.75M53.46M43.24M33.26M36.72M33.64M23.59M22.63M19.32M16.9M13.92M9.62M10.66M7.98M4.1M6.5M1.8M
Net Interest Income8.31M9.31M10M7.15M2.1M66K1.71M3.91M2.75M1.29M683K207K150K127K328K236K198K614K1.71M1.82M00000000000
Interest Income8.31M9.31M10M7.15M2.1M66K1.71M3.91M2.75M1.29M683K207K150K127K328K236K198K614K1.72M1.83M00000000000
Interest Expense00000000000000000011K14K00000000001.6M
Other Income/Expense35.14M27.51M27.81M24.57M-8.61M16.91M13.69M19.08M1.86M10.46M7.21M2.2M4.42M8M4.13M1.36M3.47M3.76M1.77M3.68M3.39M2.24M1.08M794K720K1.01M2.06M1.27M1.2M900K-1.2M
Pretax Income151.88M147.3M147.37M135.9M132.23M125.84M96.94M104.19M93.32M82.51M69.12M71.13M67.97M63.95M61.75M54.82M46.71M37.02M38.49M33.63M23.58M22.62M20.4M17.7M14.64M10.63M12.72M9.25M5.5M7.4M300K
Pretax Margin %25.19%25.31%26.39%25.32%25.76%26.99%24.24%24.97%24.59%23.72%21.94%22.74%22.31%21.59%21.1%20.12%18.78%16.25%16.82%16.39%13.99%14.57%13.47%12.67%11.61%10.17%12.52%9.92%6.43%10.07%0.51%
Income Tax42.95M41.29M38.37M35.56M29.9M24.64M14.38M21.73M21.06M41.2M21.64M27.53M27.26M25.3M24.52M22.12M19.19M14.89M15.33M13.28M9.38M8.43M8.36M7.53M6.72M4.51M5.29M3.84M1.4M3M300K
Effective Tax Rate %28.28%28.03%26.04%26.16%22.61%19.58%14.84%20.86%22.57%49.94%31.31%38.71%40.11%39.57%39.72%40.36%41.08%40.23%39.83%39.51%39.8%37.28%40.99%42.55%45.87%42.4%41.59%41.52%25.45%40.54%100%
Net Income108.93M106.01M109M100.34M102.33M101.2M82.55M82.46M72.25M41.3M47.48M43.6M40.7M38.64M37.23M32.7M27.52M22.13M23.16M20.34M14.19M14.19M12.04M10.17M7.92M6.12M7.78M5.19M4.1M4.3M-400K
Net Margin %18.07%18.21%19.52%18.69%19.94%21.7%20.64%19.77%19.04%11.88%15.07%13.94%13.36%13.05%12.72%12%11.06%9.71%10.12%9.92%8.42%9.14%7.95%7.28%6.29%5.86%7.66%5.56%4.8%5.85%-0.68%
Net Income Growth %3.24%-2.75%8.63%-1.95%1.11%22.59%0.11%14.13%74.93%-13.01%8.9%7.12%5.33%3.8%13.86%18.8%24.38%-4.46%13.86%43.31%0.06%17.82%18.43%28.29%29.43%-21.33%50%26.54%-4.65%1175%-120%
Net Income (Continuing)108.93M106.01M109M100.34M102.33M101.2M82.55M82.46M72.25M41.3M47.48M43.6M40.7M38.64M37.23M32.7M27.52M22.13M23.16M20.34M14.19M14.19M12.04M10.17M7.92M6.12M7.43M5.41M3.9M4.4M1.8M
Discontinued Operations0000000000000000000000000000000
Minority Interest0000000000000000000000000000000
EPS (Diluted)2.172.072.111.941.961.901.551.531.330.770.870.800.740.690.650.560.460.370.370.310.210.200.180.160.130.110.140.090.070.07-0.01
EPS Growth %4.88%-1.9%8.76%-1.02%3.16%22.58%1.31%15.04%72.73%-11.49%8.75%8.11%7.25%6.15%16.07%21.74%24.32%0%19.35%47.62%5%11.11%12.5%23.08%18.18%-21.43%49.25%41.48%-8.55%--120%
EPS (Basic)-2.082.131.961.981.921.581.571.370.780.900.820.760.710.680.580.480.390.390.340.220.220.200.180.140.120.150.100.070.08-0.01
Diluted Shares Outstanding50.12M51.24M51.57M51.63M52.28M53.33M53.32M53.88M54.17M53.97M54.33M54.6M55.33M56.1M57.17M59M60.28M60.12M62.9M65.29M68.78M70.15M68.3M63.97M60.3M57.41M56.71M55.15M61.67M59.08M53.33M
Basic Shares Outstanding49.79M50.9M51.13M51.15M51.73M52.61M52.39M52.69M52.91M52.72M52.98M53.21M53.82M54.46M55.12M56.72M57.42M56.74M58.84M60.03M63.53M64.85M61.66M57.57M54.42M52.05M53.05M54M59.14M57.18M53.33M
Dividend Payout Ratio-58.05%53.41%53.86%48.12%42.68%48.18%40.63%37.67%52.86%39.56%35.89%32.08%20.52%-----------------

Key Metrics

Growth RegimeAccelerating
ProfitabilityStrong
Balance SheetFortress
Cash FlowRobust
Top Statement Risk

STEM Talent Wage Inflation

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Revenue Growth Momentum Accelerates Sharply

According to recent financial disclosures, Exponent's revenue growth accelerated to 14.3% in 2026Q1, marking a significant departure from the mid-single-digit growth observed in previous quarters and suggesting that the firm's specialized forensic consulting services are capturing increased demand within complex technological and regulatory environments.

The recent revenue surge indicates that Exponent is successfully scaling its high-value forensic engagements, likely benefiting from the increasing complexity of systemic failures in emerging sectors. Investors should monitor whether this acceleration is sustainable or if it reflects the lumpy, project-based nature of litigation-driven consulting work.

Structural Margin Volatility Masks Efficiency

As reported in quarterly income statements, Exponent's gross margins have exhibited significant period-to-period fluctuations, ranging from 16.4% to 94.5% due to accounting anomalies, which complicates the assessment of underlying pricing power and the true profitability of its core engineering and scientific consulting services.

The extreme variance in reported gross margins appears to be driven by the inconsistent treatment of pass-through reimbursable expenses rather than fundamental shifts in service pricing. Analysts should focus on normalized margins to determine if the firm maintains its premium positioning against boutique competitors in the forensic space.

Operating Leverage Remains Highly Sensitive

Based on the provided income statement data, Exponent's operating margins have fluctuated between 12.1% and 30.5% over the last ten quarters, demonstrating that the firm's profitability is highly sensitive to the utilization rates of its specialized PhD-level workforce and the management of fixed overhead costs.

The firm's ability to scale operating income appears directly tied to its capacity to maintain high billable hour utilization across its 90 technical disciplines. Any sustained decline in utilization could lead to rapid margin compression, given the high fixed cost of maintaining a specialized, credentialed expert bench.

Stock-Based Compensation Impacts Earnings Quality

Analysis of recent filings reveals that Exponent consistently utilizes stock-based compensation, with quarterly expenses reaching as high as $9.1 million in 2026Q1, which serves as a critical retention tool for specialized talent but simultaneously creates a persistent drag on reported net income and shareholder dilution.

While stock-based compensation is essential for retaining PhD-level experts in a competitive labor market, the magnitude of these grants warrants careful scrutiny regarding their impact on long-term EPS growth. Investors should evaluate whether the value generated by these experts justifies the ongoing dilution of the equity base.

Talent Scarcity Risks Margin Sustainability

Financial trends suggest that Exponent faces intensifying competition for specialized STEM talent, which may force wage inflation that exceeds the firm's ability to raise billable rates, potentially capping future operating margin expansion despite the strong demand for its forensic and failure analysis consulting services.

The reliance on a highly credentialed workforce creates a structural vulnerability where labor cost inflation could erode the firm's competitive advantage. If Exponent cannot pass these rising costs through to clients, the current profitability profile may prove unsustainable in the face of aggressive hiring by technology firms.

EXPO — Frequently Asked Questions

Quick answers to the most common questions about buying EXPO stock.

What was Exponent, Inc.'s (EXPO) revenue in 2025?

For fiscal year 2025, Exponent, Inc. (EXPO) reported total revenue of $582.0M. This represents a 891.5% increase compared to $58.7M in 1996.

Is Exponent, Inc. (EXPO) profitable?

Exponent, Inc. (EXPO) is profitable, generating $106.0M in net income for the fiscal year ending 2025 with a net profit margin of 18.2%.

What is Exponent, Inc.'s operating profit margin?

Exponent, Inc. (EXPO) reported an operating income of $119.8M, resulting in an operating profit margin of 20.6%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Exponent, Inc.'s gross profit and gross margin?

Exponent, Inc. (EXPO) generated $145.3M in gross profit for the year, representing a gross profit margin of 25.0%. This demonstrates the company's core pricing power and production efficiency.